Table 1

Histological features of cases of primary T cell lymphoma of the salivary glands described in the literature (including our case)

Refs	Sex	Age	Ethnic origin	Family history	Site of disease	Histology	EBV status (ISH or IHC)	Treatment	Survival
EBV, Epstein-Barr virus; ICH, immunohistochemistry; ISH, in situ hybridisation; MACOB, methotrexate, adriamycin (doxorubicin), cyclophosphamide, oncovin (vincristine), and prednisolone; N/A, data not available/commented on in the original literature; NHL, non-Hodgkin's lymphoma; NK, natural killer cell.
4	M	46	Chinese	N/A	Submandibular	T-NHL	Negative	N/A	6 months
	M	65	Chinese	N/A	Parotid	T-NHL	Negative	N/A	36 months
	M	24	Chinese	N/A	Submandibular	T/NK angiocentric	Positive	N/A	6 weeks
	M	64	Chinese	N/A	Parotid	T/NK	Positive	N/A	5 months
	M	63	Chinese	N/A	Submandibular	T/NK angiocentric	Positive	Multimodality treatment not otherwise specified	>18 months
	M	62	Chinese	N/A	Parotid	T anaplastic large cell	Negative	Multimodality treatment not otherwise specified	>48 months
3	N/A	N/A	Chinese	N/A	Sublingual	T-NHL	Positive	N/A	N/A
	N/A	N/A	Chinese	N/A	Sublingual	T-NHL	Positive	N/A	N/A
	N/A	N/A	Chinese	N/A	Submandibular	T-NHL	Positive	N/A	N/A
5	M	48	N/A	N/A	Parotid	T anaplastic large cell	N/A	N/A	N/A
	M	71	N/A	N/A	Parotid	T anaplastic large cell	N/A	N/A	N/A
	N/A	N/A	N/A	N/A	N/A	T-NHL	N/A	N/A	N/A
6	M	79	N/A		Submandibular	T-NHL pleomorphic	Positive	Chemotherapy MACOP
7	N/A	N/A	N/A	N/A	N/A	Peripheral T cell	N/A	N/A	N/A
Our case	M	69	White	Nil	Parotid	T-NHL	Negative	See text	>30 months